UNSPSC 51142533: Memantine

This classification denotes a neuroprotective agent and antiparkinsonian agent with the molecular formula C12H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W8O17SJF3T, chemically known as 3,5-dimethyltricyclo(3.3.1.1(3,7))decan-1-amine but generally known as memantine, which bears US NIH Compound Identifier 4054. European Medicines Agency schedules Memantine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08731MIG.

UNSPSC 51142533 Memantine is a Commodity code for a specific pharmaceutical product, but the recent state and local procurement activity tagged under it does not reflect memantine procurement. Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 seeking naloxone and safe drug deactivation systems — products entirely unrelated to memantine, an Alzheimer's-disease treatment. The code shows little relevant recent activity aligned with its nominal pharmaceutical scope.

The single available opportunity, Seminole County IFB 60459723LAS with a response deadline of July 26, 2023, represents a community health initiative for opioid-response and drug-disposal products rather than memantine or similar cognitive therapeutics. Given the mismatch between the code's intended scope and actual solicitation activity, procurement professionals should verify the correct UNSPSC classification for memantine opportunities or monitor whether state and local health systems begin issuing RFPs or ITBs explicitly targeting memantine for aging-services programs, institutional care, or pharmacy benefit management. No other recent opportunities under this code appear in the source.